![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 15, 12992-13002, April 11, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the University of Washington, Department of Pharmacology,
School of Medicine, Health Sciences Center, Box 357280, Seattle,
Washington 98195-7280
Cyclin D1 is an oncogene that regulates
progression through the G1 phase of the cell
cycle. A temperature-sensitive missense mutation in the transcription
factor TAF1/TAFII250 induces the mutant ts13 cells to
arrest in late G1 by decreasing transcription of cell cycle
regulators, including cyclin D1. Here we provide evidence that TAF1
serves two independent functions, one at the core promoter and one at
the upstream activating Sp1 sites of the cyclin D1 gene. Using in
vivo genomic footprinting, we have identified protein-DNA
interactions within the cyclin D1 core promoter that are disrupted upon
inactivation of TAF1 in ts13 cells. This 33-bp segment, which we termed
the TAF1-dependent element 1 (TDE1), contains an initiation
site that displays homology to the consensus motif and is sufficient to
confer a requirement for TAF1 function. Electrophoretic mobility shift
assays reveal that binding of ts13-TAF1-containing TFIID complexes to
the cyclin D1 TDE1 occurs at 25 °C but not at 37 °C in
vitro and involves the initiator element.
Temperature-dependent DNA binding activity is also observed
for TAF1-TAF2 heterodimers assembled with the ts13 mutant but not the
wild-type TAF1 protein. These data suggest that a function of TAF is
required for the interaction of TFIID with the cyclin D1 initiator. Our
finding that recruitment of TFIID, by insertion of a TBP binding site
upstream of the TDE1, restores basal but not activated transcription
supports the model that TAF1 carries out two independent functions at
the cyclin D1 promoter.
Transcription Factor IID Recruitment and Sp1 Activation
DUAL FUNCTION OF TAF1 IN CYCLIN D1 TRANSCRIPTION*
and
*
This work was supported in part by research project Grant
RPG-98-201-CCG from the American Cancer Society.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by National Research Service Award GM7750 from NIGMS,
the National Institutes of Health.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF539477.
§ To whom correspondence should be addressed: Dept. of Pharmacology, School of Medicine, Health Sciences Center, Box 357280, Seattle, WA 98195-7280. Tel.: 206-616-5376; Fax: 206-685-3822; E-mail: ehwang@u.washington.edu.This article has been cited by other articles:
![]() |
D Bonofiglio, H Qi, S Gabriele, S Catalano, S Aquila, M Belmonte, and S Ando Peroxisome proliferator-activated receptor {gamma} inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner Endocr. Relat. Cancer, June 1, 2008; 15(2): 545 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Mal, S. Takahata, S. Ki, L. Zheng, T. Kokubo, and M. Ikura Functional Silencing of TATA-binding Protein (TBP) by a Covalent Linkage of the N-terminal Domain of TBP-associated Factor 1 J. Biol. Chem., July 27, 2007; 282(30): 22228 - 22238. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Yao, Y.-C. Lin, P. Sawhney, and J. H. Richburg Transcriptional Regulation of FasL Expression and Participation of sTNF-{alpha} in Response to Sertoli Cell Injury J. Biol. Chem., February 23, 2007; 282(8): 5420 - 5431. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B Silberstein, K. Van Horn, E. Hrabeta-Robinson, and J. Compton Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system. J. Endocrinol., August 1, 2006; 190(2): 225 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rossi, R. Mukerjee, P. Ferrante, K. Khalili, S. Amini, and B. E. Sawaya Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes J. Gen. Virol., June 1, 2006; 87(6): 1613 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Das, S. V. Ward, R. S. Tacke, G. Suske, and C. E. Samuel Activation of the RNA-dependent Protein Kinase PKR Promoter in the Absence of Interferon Is Dependent Upon Sp Proteins J. Biol. Chem., February 10, 2006; 281(6): 3244 - 3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, N. Gershenzon, M. Gupta, I. P. Ioshikhes, D. Reinberg, and B. A. Lewis Functional Characterization of Core Promoter Elements: the Downstream Core Element Is Recognized by TAF1 Mol. Cell. Biol., November 1, 2005; 25(21): 9674 - 9686. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Gallagher, D. G. Nilson, C. Wong, J. L. Weisbein, L. J. Garrett-Beal, S. W. Eber, and D. M. Bodine A dinucleotide deletion in the ankyrin promoter alters gene expression, transcription initiation and TFIID complex formation in hereditary spherocytosis Hum. Mol. Genet., September 1, 2005; 14(17): 2501 - 2509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ongeri, M. F. Verderame, and J. M. Hammond Follicle-Stimulating Hormone Induction of Ovarian Insulin-Like Growth Factor-Binding Protein-3 Transcription Requires a TATA Box-Binding Protein and the Protein Kinase A and Phosphatidylinositol-3 Kinase Pathways Mol. Endocrinol., July 1, 2005; 19(7): 1837 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Badran, K. Kunstman, J. Stanton, M. Moschitta, A. Zerghe, H. Akl, A. Burny, S. M. Wolinsky, and K. E. Willard-Gallo Transcriptional Regulation of the Human CD3{gamma} Gene: The TATA-Less CD3{gamma} Promoter Functions via an Initiator and Contiguous Sp-Binding Elements J. Immunol., May 15, 2005; 174(10): 6238 - 6249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amini, M. Saunders, K. Kelley, K. Khalili, and B. E. Sawaya Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes J. Biol. Chem., October 29, 2004; 279(44): 46046 - 46056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Buchmann, J. R. Skaar, and J. A. DeCaprio Activation of a DNA Damage Checkpoint Response in a TAF1-Defective Cell Line Mol. Cell. Biol., June 15, 2004; 24(12): 5332 - 5339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Dehm, T. L. Hilton, E. H. Wang, and K. Bonham SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase Inhibitors Mol. Cell. Biol., March 15, 2004; 24(6): 2296 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fuchs, C. Y. Inwards, and R. Janknecht Vascular Endothelial Growth Factor Expression is Up-Regulated by EWS-ETS Oncoproteins and Sp1 and May Represent an Independent Predictor of Survival in Ewing's Sarcoma Clin. Cancer Res., February 15, 2004; 10(4): 1344 - 1353. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |